Proton magnetic resonance spectroscopy
clinical applications in patients with brain lesions
Keywords:
Proton, Spectroscopy, Magnetic resonance, BrainAbstract
CONTEXT: Proton spectroscopy has been recognized as a safe and noninvasive diagnostic method that, coupled with magnetic resonance imaging techniques, allows for the correlation of anatomical and physiological changes in the metabolic and biochemical processes occurring within previouslydetermined volumes in the brain. There are two methods of proton magnetic resonance spectroscopy: single voxel and chemical shift imaging OBJECTIVE: The present work focused on the clinical applications of proton magnetic resonance spectroscopy in patients with brain lesions. CONCLUSIONS: In vivo proton spectroscopy allows the detection of certain metabolites in brain tissue, such as N-acetyl aspartate, creatine, choline, myoinositol, amino acids and lipids, among others. N-acetyl aspartate is a neuronal marker and, as such, its concentration will decrease in the presence of aggression to the brain. Choline increase is the main indicator of neoplastic diseases. Myoinositol is raised in patients with Alzheimer’s disease. Amino acids are encountered in brain abscesses. The presence of lipids is related to necrotic processes.
Downloads
References
Lenkinski RE, Schnall MD. MR Spectroscopy and the biochemi- cal basis of neurological disease. In: Atlas SW, editor. Magnetic resonance imaging of the brain and spine. Philadelphia: Lippincott-Raven; 1996. p.1619-53.
Alger JR, Frank JA, Bizzi A, et al. Metabolism of human glio- mas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET. Radiology 1990;177(3):633-41.
Luyten PR, Marien AJ, Heindel W, et al. Metabolic imaging of patients with intracranial tumors: H-1 MR spectroscopic imaging and PET. Radiology 1990;176(3):791-9.
Norfray J, Byrd SE, Schwalm CA. Magnetic resonance spectroscopy. In: McLone DG, ed. Pediatric neurosurgery. Phila- delphia: WB Saunders; 2001. p.1189-203.
Kuzniecky R. Magnetic resonance spectroscopy in focal epi- lepsy: 31P and 1H spectroscopy. Rev Neurol 1999;155(6- 7):495-8.
Ross B, Michaelis T. MR spectroscopy of the brain: neurospectroscopy. In: Hesselink JR, Zlatkin MB, Edelman RR, editors. Clinical magnetic resonance imaging. Philadelphia: WB Saunders; 1996. p.928-81.
van der Knaap MS, van der Grond J, van Rijen PC, Faber JA, Valk J, Willemse K. Age-dependent changes in localized proton and phosphorus MR spectroscopy of the brain. Radiology 1990;176(2):509-15.
Peeling J, Sutherland G, Marat K, Tomchuk E, Bock E. 1H and 13C nuclear magnetic resonance studies of plasma from pa- tients with primary intracranial neoplasms. J Neurosurg 1988;68(6):931-7.
Gruetter R. Localized 13C NMR spectroscopy in vivo. In: Week- end Educational Courses: MR spectroscopy. Honolulu: Inter- national Society for Magnetic Resonance in Medicine; 2002. p.88-95.
Weiner MW, Hetherington HP. The power of the proton. Ra- diology 1989;172(2):318-20.
Frahm J, Bruhn H, Gyngell ML, et al. Localized high-resolu- tion proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo. Magn Reson Med 1989;9(1):79-83.
Frahm J, Bruhn H, Gyngell ML, et al. Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites. Magn Reson Med 1989;11(1):47-63.
Kwock L. Localized MR spectroscopy: basic principles. Neuroimaging Clin N Am 1998;8(4):713-31.
Butzen J, Prost R, Chetty V, Donahue K, Neppl R, Bowen W, et al. Discrimination between neoplastic and nonneoplastic brain lesions by use of proton MR spectroscopy: the limits of accu- racy with a logistic regression model. AJNR Am J Neuroradiol 2000;21(7):1213-9.
Wilken B, Dechent P, Herms J, et al. Quantitative proton mag- netic resonance spectroscopy of focal brain lesions. Pediatr Neurol 2000;23(1):22-31.
Adamson AJ, Rand SD, Prost RW, et al. Focal brain lesions: effect of single-voxel proton MR spectroscopic findings on treat- ment decisions. Radiology 1998;209(1):73-8.
Simone IL, Federico F, Tortorella C, et al. Localised 1H-MR spectroscopy for metabolic characterisation of diffuse and focal brain lesions in patients infected with HIV. J Neurol Neurosurg Psychiatry 1998;64(4):516-23.
Poptani H, Kaartinen J, Gupta RK, et al. Diagnostic assess- ment of brain tumours and non-neoplastic brain disorders in vivo using proton nuclear magnetic resonance spectroscopy and artificial neural networks. J Cancer Res Clin Oncol 1999;125(6):343-9.
Kaibara T, Tyson RL, Sutherland GR. Human cerebral neo- plasms studied using MR spectroscopy: a review. Biochem Cell Biol 1998;76(2-3):477-86.
Cecil KM, Lenkinski RE. Proton MR spectroscopy in inflam- matory and infectious brain disorders. Neuroimaging Clin N Am 1998;8(4):863-80.
Chang L, Miller BL, McBride D, et al. Brain lesions in pa- tients with AIDS: H-1 MR spectroscopy. Radiology 1995;197(2):525-31.
Chinn RJ, Wilkinson ID, Hall-Craggs MA, et al. Toxoplasmo- sis and primary central nervous system lymphoma in HIV in- fection: diagnosis with MR spectroscopy. Radiology 1995;197(3):649-54.
Chang L, Ernst T. Proton MRS to assess HIV-related brain dis- eases. In: Weekend Educational Courses: MR spectroscopy. Honolulu: International Society for Magnetic Resonance in Medicine; 2002. p.48-55.
Shonk TK, Moats RA, Gifford P, et al. Probable Alzheimer dis- ease: diagnosis with proton MR spectroscopy. Radiology 1995;195(1):65-72.
Castillo M, Kwock L, Mukherji SK. Clinical applications of proton MR spectroscopy. AJNR Am J Neuroradiol 1996;17(1):1-15.
Ross BD, Bluml S, Cowan R, et al. In vivo MR spectroscopy of human dementia. Neuroimaging Clin N Am 1998;8(4):809-22.
Cwik VA, Hanstock CC, Allen PS, et al. Estimation of brainstem neuronal loss in amyotrophic lateral sclerosis with in vivo pro- ton magnetic resonance spectroscopy. Neurology 1998;50(1):72-7.
Bizzi A, Movsas B, Tedeschi G, et al. Response of non-Hodgkin lymphoma to radiation therapy: early and long-term assessment with H-1 MR spectroscopic imaging. Radiology 1995;194(1):271-6.
Davidson A, Tait DM, Payne GS, et al. Magnetic resonance spectroscopy in the evaluation of neurotoxicity following cra- nial irradiation for childhood cancer. Br J Radiol 2000;73(868):421-4.
Yoshino E, Ohmori Y, Imahori Y, et al. Irradiation effects on the metabolism of metastatic brain tumors: analysis by posi- tron emission tomography and 1H-magnetic resonance spectroscopy. Stereotact Funct Neurosurg 1996;66(Suppl 1):240-59.
Bruhn H, Frahm J, Merboldt KD, et al. Multiple sclerosis in children: cerebral metabolic alterations monitored by localized proton magnetic resonance spectroscopy in vivo. Ann Neurol 1992;32(2):140-50.
De Stefano N, Caramanos Z, Preul MC, et al. In vivo differ- entiation of astrocytic brain tumors and isolated demyelinat- ing lesions of the type seen in multiple sclerosis using 1H magnetic resonance spectroscopic imaging. Ann Neurol 1998;44(2):273-8.
Rovira A, Pericot I, Alonso J, Rio J, Grive E, Montalban X. Serial diffusion-weighted MR imaging and proton MR spectroscopy of acute large demyelinating brain lesions: case report. AJNR Am J Neuroradiol 2002;23(6):989-94.
Bonavita S, Di Salle F, Tedeschi G. Proton MRS in neurologi- cal disorders. Eur J Radiol 1999;30(2):125-31.
Ricci PE Jr. Proton MR spectroscopy in ischemic stroke and other vascular disorders. Neuroimaging Clin N Am 1998:8(4):881-900.
Malisza KL, Kozlowski P, Peeling J. A review of in vivo 1H magnetic resonance spectroscopy of cerebral ischemia in rats. Biochem Cell Biol 1998;76(2-3):487-96.
Wang Z, Zimmerman RA, Sauter R. Proton MR spectroscopy of the brain: clinically useful information obtained in assessing CNS diseases in children. AJR Am J Roentgenol 1996;167(1):191-9.
Friedman SD, Brooks WM, Jung RE, et al. Quantitative pro- ton MRS predicts outcome after traumatic brain injury. Neu- rology 1999;52(7):1384-91.
Schuhmann MU, Stiller D, Thomas S, Brinker T, Samii M. 1H-MR spectroscopic monitoring of posttraumatic metabolism following controlled cortical impact injury: pilot study. Acta Neurochir Suppl 2000;76:3-7.
Sinson G, Bagley LJ, Cecil KM, et al. Magnetization transfer imaging and proton MR spectroscopy in the evaluation of ax- onal injury: correlation with clinical outcome after traumatic brain injury. AJNR Am J Neuroradiol 2001;22(1):143-51.
Garnett MR, Blamire AM, Rajagopalan B, Styles P, Cadoux- Hudson TA. Evidence for cellular damage in normal-appearing white matter correlates with injury severity in patients follow- ing traumatic brain injury: a magnetic resonance spectroscopy study. Brain 2000;123(Pt 7):1403-9.
Gupta RK, Vatsal DK, Husain N, et al. Differentiation of tu- berculous from pyogenic brain abscesses with in vivo proton MR spectroscopy and magnetization transfer MR imaging. AJNR Am J Neuroradiol 2001;22(8):1503-9.
Kuzniecky R, Hetherington H, Pan J, et al. Proton spectroscopic imaging at 4.1 tesla in patients with malformations of cortical development and epilepsy. Neurology 1997;48(4):1018-24.
Cendes F, Caramanos Z, Andermann F, Dubeau F, Arnold DL. Proton magnetic resonance spectroscopic imaging and magnetic resonance imaging volumetry in the lateralization of temporal lobe epilepsy: a series of 100 patients. Ann Neurol 1997;42(5):737-46.
Mendes-Ribeiro JA, Soares R, Simões-Ribeiro F, Guimarães ML. Reduction in temporal N-acetylaspartate and creatine (or choline) ratio in temporal lobe epilepsy: does this 1H-magnetic resonance spectroscopy finding mean poor seizure control? J Neurol Neurosurg Psychiatry 1998;65(4):518-22.
Kreis R, Ross BD, Farrow NA, Ackerman Z. Metabolic disor- ders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology 1992;182(1):19-27.
Ross BD, Jacobson S, Villamil F, et al. Subclinical hepatic en- cephalopathy: proton MR spectroscopic abnormalities. Radi- ology 1994;193(2):457-63.
Sutton LN, Wang Z, Gusnard D, et al. Proton magnetic reso- nance spectroscopy of pediatric brain tumors. Neurosurgery 1992;31(2):195-202.
Taylor JS, Ogg RJ, Langston JW. Proton MR spectroscopy of pediatric brain tumors. Neuroimaging Clin N Am 1998;8(4):753-79.
Hunter JV, Wang ZJ. MR spectroscopy in pediatric neuroradiology. Magn Reson Imaging Clin N Am 2001;9(1):165-89.
Westbrook C, Kaut C. Ressonância magnética prática. Rio de Janeiro: Guanabara Koogan; 2000.
Barker PB. Fundamentals of clinical MRS. In:. Weekend Edu- cational Courses: MR spectroscopy. Honolulu: International Society for Magnetic Resonance in Medicine; 2002. p.1-9.
Negendank WG, Sauter R, Brown TR, et al. Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg 1996;84(3):449-58.
Maudsley AA. Spectroscopic imaging. In: Weekend Educational Courses: MR spectroscopy. Honolulu: International Society for Magnetic Resonance in Medicine; 2002. p.7-23.
Dowling C, Bollen AW, Noworolski SM, et al. Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens. AJNR Am J Neuroradiol 2001;22(4):604-12.
Fulham MJ, Bizzi A, Dietz MJ, et al. Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. Radiology 1992;185(3):675-86.
Moonen CT, von Kienlin M, van Zijl PC, et al. Comparison of single-shot localization methods (STEAM and PRESS) for in vivo proton NMR spectroscopy. NMR Biomed 1989;2(5- 6):201-8.
Hwang JH, Egnaczyk GF, Ballard E, et al. Proton MR spectroscopic characteristics of pediatric pilocytic astrocytomas. AJNR Am J Neuroradiol 1998;19(3):535-40.
Frahm J, Bruhn H, Hänicke W, et al. Localized proton NMR spectroscopy of brain tumors using short-echo time STEAM sequences. J Comput Assist Tomogr 1991;15(6):915-22.
Norfray JF, Tomita T, Byrd SE, et al. Clinical impact of MR spectroscopy when MR imaging is indeterminate for pediatric brain tumors. AJR Am J Roentgenol 1999;173(1):119-25.
Bottomley PA. Spatial localization in NMR spectroscopy in vivo. Ann N Y Acad Sci 1987;508:333-48.
Alger JR. Magnetic resonance spectroscopy and neuro-oncol- ogy. In:. Weekend Educational Courses: MR Espectroscopia de prótin. Honolulu: International Society for Magnetic Resonance in Medicine; 2002. p.39-43.
Brandão LA, Domingues RC. Espectroscopia de próton do encéfalo: princípios e aplicações. Rio de Janeiro: Revinter; 2002.
Le Bas JF, Estève F, Grand S, et al. Spectroscopie RMN et pathologie cérébrale. Applications cliniques. [NMR spectroscopy and brain diseases. clinical applications]. J Neuroradiol 1998;25(1):55-69.
Grand S, Passaro G, Ziegler A, et al. Necrotic tumor versus brain abscess: importance of amino acids detected at 1H MR spectroscopy - initial results. Radiology 1999;213(3):785-93.
Byrd SE, Tomita T, Palka PS, et al.. Magnetic resonance spectroscopy (MRS) in the evaluation of pediatric brain tumors, Part II: Clinical analysis. J Natl Med Assoc 1996;88(11):717-23.
Kinoshita Y, Kajiwara H, Yokota A, Koga Y. Proton magnetic resonance spectroscopy of brain tumors: an in vitro study. Neu- rosurgery 1994;35(4):606-13; discussion 613-4.
Kim DG, Choe WJ, Chang KH, et al. In vivo proton magnetic resonance spectroscopy of central neurocytomas. Neurosurgery 2000;46(2):329-33; discussion 333-4.
Norfray JF, Darling C, Byrd S, et al. Short TE proton MRS and neurofibromatosis type 1 intracranial lesions. J Comput Assist Tomogr 1999;23(6):994-1003.
Auer DP, Gössl C, Schirmer T, Czisch M. Improved analysis of 1H-MR spectra in the presence of mobile lipids. Magn Reson Med 2001;46(3):615-8.
Hakumäki JM, Kauppinen RA. 1H NMR visible lipids in the life and death of cells. Trends Biochem Sci 2000;25(8):357-62.
Castillo M, Smith JK, Kwock L. Correlation of myo-inositol levels and grading of cerebral astrocytomas. AJNR Am J Neuroradiol 2000;21(9):1645-9.
Kimura T, Sako K, Gotoh T, Tanaka K, Tanaka T. In vivo sin- gle-voxel proton MR spectroscopy in brain lesions with ring- like enhancement. NMR Biomed 2001;14(6):339-49.
Kadota O, Kohno K, Ohue S, Kumon Y, Sakaki S, Kikuchi K, et al. Discrimination of brain abscess and cystic tumor by in vivo proton magnetic resonance spectroscopy. Neurol Med Chir 2001;41(3):121-6.
Schlemmer HP, Bachert P, Herfarth KK, Zuna I, Debus J, van Kaick G. Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy. AJNR Am J Neuroradiol 2001;22(7):1316-24.
